You just read:

BioLineRx Announces Initiation of Phase 3 GENESIS Trial in Stem-Cell Mobilization for Autologous Transplantation in Multiple Myeloma Patients

News provided by

BioLineRx Ltd.

Dec 21, 2017, 06:00 EST